BC TALKS - From Risk to Results: advancing care with abemaciclib in HR+ HER2- EBC & MBC

المقدمة
سجل الان

Join us for a live webinar with oncologists top thought leaders across the globe

الأهداف

To provide attendees with a comprehensive understanding of early breast cancer, including its etiology, pathogenesis, clinical presentation, and diagnostic approaches with clinical patient cases

المستهدفين :

Physician ( Oncology )

Resident / Fellow ( Oncology )

المتحدثين

Prof. Carlos Barrios M.D., Ph.D

Director and Principal Investigator of the Oncology Research Center at Hospital São Lucas, PUCRS; President of LACOG (Latin American Cooperative Oncology Group); and Oncologist at the Oncoclínicas Group in Porto Alegre, Brazil.

Prof. Marc Thill M.D., Ph.D.

Director of the Department of Gynecology and Gynecologic Oncology and serves as the spokesperson of the Interdisciplinary Breast Cancer and the Oncological Center at the Agaplesion Markus Hospital in Frankfurt am Main, Germany.

Prof. Carmen Criscitiello M.D., Ph.D

Associate Professor at the University of Milan and Scientist & Senior Staff Member in the Division of Experimental Therapeutics at the European Institute of Oncology, Milan, Italy.